| 代码 | 简称 | 成交金额（万港元） | 成交净买入（万港元） | 今日涨跌幅（%） | | --- | --- | --- | --- | --- | | 02800 | 盈富基金 | 168930.04 | 167445.82 | 0.49 | | 01801 | 信达生物 | 107997.43 | 65111.55 | 1.15 | | 03690 | 美团-W | 297605.60 | 33808.84 | 0.56 | | 00981 | 中芯国际 | 327427.12 | 31778.77 | -2.57 | | 01053 | 重庆钢铁股份 | 372082.05 | 14480.05 | 91.11 | | 09992 | 泡泡玛特 | 72452.38 | 12269.52 | -3.15 | | 01530 | 三生制药 | 93771.70 | 10950.80 | 2.54 | | 00314 | 思派健康 | 167450.55 | 8001.87 | 8.62 | | 01788 | 国泰君安国际 | 287269.20 | -48.58 | 0.87 | | 0093 ...

道指跌0.02%，标普500指数跌0.08%，纳指跌0.07%。特斯拉(TSLA.O)开涨2.8%，公司二季度交付量略 低于预期，微软(MSFT.O)开跌0.47%，据悉其将在第二轮大规模裁员中裁减9000名员工。 "小非农"超预期爆冷 美三大股指小幅低开 ...

纳斯达克综合指数7月2日（周三）开盘下跌13.43点，跌幅0.07%，报20189.46点； 标普500指数7月2日（周三）开盘下跌6.50点，跌幅0.10%，报6191.51点； 道琼斯指数7月2日（周三）开盘下跌88.33点，跌幅0.20%，报44406.61点。 ...

Company Overview - Snap's shares increased by 7.6% to $9.35 in the last trading session, with a higher-than-average trading volume, compared to a 6% gain over the past four weeks [1] - The company is approaching its goal of 1 billion monthly active users (MAU), having surpassed 900 million MAU in April, with significant growth in markets like India, where MAU exceeded 250 million [2] Financial Performance - Snap is expected to report quarterly earnings of $0.00 per share, reflecting a year-over-year decline of 100%, while revenues are projected to be $1.34 billion, an 8% increase from the previous year [3] - The consensus EPS estimate for Snap has been revised 1.6% higher in the last 30 days, indicating a positive trend that may lead to price appreciation [4] Industry Context - Snap operates within the Zacks Internet - Software industry, where Tuya Inc. also competes, having closed the last trading session at $2.33 with a -4.6% return over the past month [4] - Tuya's consensus EPS estimate remains unchanged at $0.03, representing a 25% decline compared to the previous year, and it holds a Zacks Rank of 1 (Strong Buy) [5]

Key Takeaways VRTX gains EU approval for Alyftrek to treat CF patients aged six and above with non-class I mutations. Alyftrek offers once-daily dosing and potential benefits over Trikafta, including improved CFTR function. Alyftrek sales reached $53.9M in Q1 2025, with management expecting stronger uptake in H2 2025.Vertex Pharmaceuticals (VRTX) announced that the European Commission has approved Alyftrek (deutivacaftor/tezacaftor/vanzacaftor) for treating people with cystic fibrosis (“CF”) aged six year ...

Selangor, Malaysia, July 02, 2025 (GLOBE NEWSWIRE) -- Empro Group Inc. (the “Company” or “EMPG”), a rising beauty and personal care brand headquartered in Malaysia, today announced the pricing of its initial public offering (the "Offering") of 1,375,000 ordinary shares (the "Ordinary Shares") at a public offering price of $4.00 per share for total gross proceeds of approximately $5,500,000, before deducting underwriting discounts and other offering expenses. The Ordinary Shares have been approved for listin ...

Enterprise Software Sales Leaders Join to Drive AI in Process GrowthMCLEAN, Va., July 2, 2025 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced the expansion of its sales leadership team by appointing three seasoned leaders to bolster its presence and drive growth across the United Kingdom (UK), Europe, the Middle East, and Africa (EMEA). Vicky Nesbit joins as the Senior Vice President (SVP) of Sales in the UK and EMEA, Vincent Perrin takes on the role of Vice President of EMEA North, and Rob Cook will ...

VANCOUVER, British Columbia and OYEN, Alberta, July 02, 2025 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) (“AgriFORCE” or the “Company”), a technology and infrastructure firm operating at the intersection of clean energy and digital compute, today announced the successful installation and commissioning of miners at its future Oyen, Alberta site. This development marks a significant step in the Company's Power & Compute Initiative, following the launch of its first decentralized site in ...

【导读】创新药新政出台，业内人士重磅解读 创新药"王炸"政策出台，不仅二级市场沸腾了，一级市场也沸腾了。 近日，国家医保局、国家卫健委发布《支持创新药高质量发展的若干措施》（以下简称《若干措 施》）。7月1日，国家医保局召开新闻发布会，专题介绍《若干措施》相关内容。 业内普遍认为，该政策让创新药有了全链路的政策支持。受访的多位医药行业分析师和创投人士指出， 该政策通过研发端、准入与支付、临床应用多个层次的组合拳，构建了支持创新药高质量发展的闭环体 系，有望推动中国从"仿制药大国"向"创新药强国"跨越。 高特佳投资集团副总经理于建林直言，文件出台的核心逻辑是进一步促进创新药研发以临床价值为导 向，进一步拓宽创新药的支付渠道；进一步提高创新药的可及性，满足百姓多层次的用药需求。未来一 级市场创新药的投资范式将从单一研发管线估值转向"全球化+商业化+政策豁免"三维驱动。 医保数据赋能+资本破局 降低创新风险 过去十年里，我国创新药经历了飞速发展的时期：创新创投活跃、研发管线丰富。然而，同质化问题也 随之而来，靶点与管线布局也存在"追热点"的现象。 为了避免这些问题，《若干措施》提出了医保数据应用的突破性举措，即支持 ...

Since my last Celestica Inc. (NYSE: CLS ) analysis , the stock has gained 65% in price. Now is the time to trim your position.Oliver Rodzianko is the Founder and Chief Executive Officer of Invictus Origin, a pioneering high-alpha investment management firm launched in May 2025, dedicated to becoming a globally recognized, actively managed fund. Invictus Origin is developing innovative portfolio strategies, notably through its flagship Nasdaq High-Alpha Black Swan Portfolio, strategically designed to sustain ...